Structure-activity relationship of T-cell receptors based on alanine scanning

Biochemical and Biophysical Research Communications

Volumn 415, Issue 4, 2011, Pages 558-562

  Narimatsu, Shogo ^a   Yoshioka, Yasuo ^a,b   Morishige, Tomohiro ^a   Yao, Xinglei ^a,c   Tsunoda, Shin Ichi ^a,b   Tsutsumi, Yasuo ^a,b   Nishimura, Michael I ^d   Mukai, Yohei ^a   Okada, Naoki ^a   Nakagawa, Shinsaku ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c ZHEJIANG UNIVERSITY   (China)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alanine scanning; Melanoma; Protein engineering; T cell receptor

Indexed keywords

ALANINE; AMINO ACID; CELL PROTEIN; HLA A ANTIGEN; HLA ANTIGEN; MONOPHENOL MONOOXYGENASE; MUTANT PROTEIN; T LYMPHOCYTE RECEPTOR;

AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; COMPLEMENTARITY DETERMINING REGION; COMPLEX FORMATION; MELANOMA; MOLECULAR RECOGNITION; PRIORITY JOURNAL; WILD TYPE;

ALANINE; AUTOANTIGENS; HLA-A ANTIGENS; HUMANS; MONOPHENOL MONOOXYGENASE; NERVE TISSUE PROTEINS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84855903358     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.092     Document Type: Article

References (22)

1. Wilson R.K., Lai E., Concannon P., Barth R.K., Hood L.E. Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol. Rev. 1988, 101:149-172.
2. Strominger J.L. Developmental biology of T cell receptors. Science 1989, 244:943-950.
3. Turner S.J., Doherty P.C., McCluskey J., Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 2006, 6:883-894.
4. Kessels H.W., Wolkers M.C., van den Boom M.D., van der Valk M.A., Schumacher T.N. Immunotherapy through TCR gene transfer. Nat. Immunol. 2001, 2:957-961.
5. Rossig C., Bollard C.M., Nuchtern J.G., Rooney C.M., Brenner M.K. Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy. Blood 2002, 99:2009-2016.
6. Karanikas V., Lurquin C., Colau D., van Baren N., De Smet C., Lethe B., Connerotte T., Corbiere V., Demoitie M.A., Lienard D., Dreno B., Velu T., Boon T., Coulie P.G. Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus. J. Immunol. 2003, 171:4898-4904.
7. Card K.F., Price-Schiavi S.A., Liu B., Thomson E., Nieves E., Belmont H., Builes J., Jiao J.A., Hernandez J., Weidanz J., Sherman L., Francis J.L., Amirkhosravi A., Wong H.C. A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity. Cancer Immunol. Immunother. 2004, 53:345-357.
8. Belmont H.J., Price-Schiavi S., Liu B., Card K.F., Lee H.I., Han K.P., Wen J., Tang S., Zhu X., Merrill J., Chavillaz P.A., Wong J.L., Rhode P.R., Wong H.C. Potent antitumor activity of a tumor-specific soluble TCR/IL-2 fusion protein. Clin. Immunol. 2006, 121:29-39.
9. Wen J., Zhu X., Liu B., You L., Kong L., Lee H.I., Han K.P., Wong J.L., Rhode P.R., Wong H.C. Targeting activity of a TCR/IL-2 fusion protein against established tumors. Cancer Immunol. Immunother. 2008, 57:1781-1794.
10. Khandekar S.S., Brauer P.P., Naylor J.W., Chang H.C., Kern P., Newcomb J.R., Leclair K.P., Stump H.S., Bettencourt B.M., Kawasaki E., Banerji J., Profy A.T., Jones B. Affinity and kinetics of the interactions between an alphabeta T-cell receptor and its superantigen and class II-MHC/peptide ligands. Mol. Immunol. 1997, 34:493-503.
11. Cole D.K., Pumphrey N.J., Boulter J.M., Sami M., Bell J.I., Gostick E., Price D.A., Gao G.F., Sewell A.K., Jakobsen B.K. Human TCR-binding affinity is governed by MHC class restriction. J. Immunol. 2007, 178:5727-5734.
12. Li Y., Moysey R., Molloy P.E., Vuidepot A.L., Mahon T., Baston E., Dunn S., Liddy N., Jacob J., Jakobsen B.K., Boulter J.M. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat. Biotechnol. 2005, 23:349-354.
13. Dunn S.M., Rizkallah P.J., Baston E., Mahon T., Cameron B., Moysey R., Gao F., Sami M., Boulter J., Li Y., Jakobsen B.K. Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci. 2006, 15:710-721.
14. Reiser J.B., Darnault C., Gregoire C., Mosser T., Mazza G., Kearney A., van der Merwe P.A., Fontecilla-Camps J.C., Housset D., Malissen B. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat. Immunol. 2003, 4:241-247.
15. J. Zhou, R. Ma, R. Luo, Y. Sun, X. He, W. Sun, W. Tang, X. Yao, Primary exploration of CDR3 spectratyping and molecular features of TCR beta chain in the peripheral blood and tissue of patients with colorectal carcinoma, Cancer Epidemiol 34, 733-740.
16. Nishimura M.I., Avichezer D., Custer M.C., Lee C.S., Chen C., Parkhurst M.R., Diamond R.A., Robbins P.F., Schwartzentruber D.J., Rosenberg S.A. MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte. Cancer Res. 1999, 59:6230-6238.
17. Nishimura M.I., Roszkowski J.J., Moore T.V., Brasic N., McKee M.D., Clay T.M. Antigen recognition and T-cell biology. Cancer Treat. Res. 2005, 123:37-59.
18. R.C. Koya, S. Mok, B. Comin-Anduix, T. Chodon, C.G. Radu, M.I. Nishimura, O.N. Witte, A. Ribas, Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses, Proc. Natl. Acad. Sci. USA 107 14286-14291.
19. Willcox B.E., Gao G.F., Wyer J.R., Ladbury J.E., Bell J.I., Jakobsen B.K., van der Merwe P.A. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 1999, 10:357-365.
20. Willcox B.E., Gao G.F., Wyer J.R., O'Callaghan C.A., Boulter J.M., Jones E.Y., van der Merwe P.A., Bell J.I., Jakobsen B.K. Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding. Protein Sci. 1999, 8:2418-2423.
21. Boulter J.M., Glick M., Todorov P.T., Baston E., Sami M., Rizkallah P., Jakobsen B.K. Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng. 2003, 16:707-711.
22. Varani L., Bankovich A.J., Liu C.W., Colf L.A., Jones L.L., Kranz D.M., Puglisi J.D., Garcia K.C. Solution mapping of T cell receptor docking footprints on peptide-MHC. Proc. Natl. Acad. Sci. USA 2007, 104:13080-13085.